Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Healthcare costs in the U.S. continue to rise, making it difficult for millions of people to afford essential medical ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...

The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device that stores and transfers insulin dose-related data from the pen ...

The pump-based platform will be a hybrid closed-loop device that will combine an insulin ... division – to develop connected insulin pens. “CGMs provide people with diabetes and their ...

In a report released yesterday, Victoria Lambert from Berenberg Bank maintained a Buy rating on Gerresheimer (0NTI – Research Report), with a ...

Subcutaneous Drug Delivery Devices market Growth Fueled by Chronic Diseases and Technological Innovation Akash Anand SNS Insider Pvt. Ltd 415-230-0044 email us here Visit us on social media: Facebook ...

Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick.